ID   CL-01
AC   CVCL_0082
SY   CL01; BL16 sub-line CL-01
DR   Wikidata; Q54813469
RX   PubMed=9498752;
WW   http://www.novusbio.com/about/press-release/human-monoclonal-igmigd-b-cell-line-announced-novus-biologicals
CC   Population: Africans south of the Sahara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C137 ! BL-16
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
RX   PubMed=9498752; DOI=10.4049/jimmunol.160.5.2145;
RA   Cerutti A., Zan H., Schaffer A., Bergsagel P.L., Harindranath N.,
RA   Max E.E., Casali P.;
RT   "CD40 ligand and appropriate cytokines induce switching to IgG, IgA,
RT   and IgE and coordinated germinal center and plasmacytoid phenotypic
RT   differentiation in a human monoclonal IgM+IgD+ B cell line.";
RL   J. Immunol. 160:2145-2157(1998).
//